PITTSBURGH, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Jeune Aesthetics, Inc. (“Jeune”), a wholly owned subsidiary of Krystal Biotech, Inc. (KRYS) (“Krystal”) (NASDAQ ...
–All primary and secondary endpoints were met for both Phase 3 studies (M21-500 and M21-508). –Results support BoNT/E as a novel botulinum neurotoxin serotype E characterized by a rapid onset of ...
Please provide your email address to receive an email when new articles are posted on . Results showed statistically significant improvement in platysma prominence after treatment with Botox Cosmetic ...
–All primary and secondary endpoints were met for second Phase 3 study (M21-310) and results were consistent with findings from first Phase 3 study (M21-309).–Results support onabotulinumtoxinA as a ...
Up to nine months durability of effect observed in patients aged 55 to 76 in the extension cohort following administration of high dose KB301 Mean change in Subject Satisfaction Scores from baseline ...
Aesthetic appeal Humans are drawn to beauty. We seek out what we find appealing and avoid what we find repulsive. Many of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results